| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.63B | +12.5% |
| Cost of Revenue | $920.2M | +15.8% |
| Gross Profit | $2.71B | +11.4% |
| R&D Expense | $438.0M | +1.4% |
| SG&A Expense | $1.54B | +6.5% |
| Operating Income | $617.4M | +13.7% |
| Pre-tax Income | $526.9M | +13.9% |
| Income Tax | $5.5M | +107.6% |
| Net Income | $521.5M | -2.4% |
| EPS (Basic) | $2.28 | -3.8% |
| EPS (Diluted) | $2.22 | -2.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.35B | +48.9% |
| Accounts Receivable | $676.3M | +6.9% |
| Inventory | $169.6M | -24.9% |
| Current Assets | $3.65B | +30.5% |
| Total Assets | $9.11B | +5.0% |
| Current Liabilities | $949.1M | +7.1% |
| Long-term Debt | $2.56B | -0.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.26B | +21.5% |
| Capital Expenditures | $64.0M | -16.4% |
| Investing Cash Flow | -$134.0M | +95.5% |
| Financing Cash Flow | -$348.0M | -123.7% |
| Free Cash Flow | $1.19B | +24.5% |
| Stockholders' Equity |
| $5.07B |
| +8.6% |